Seagen Inc.
Dosage and administration of non-fucosylated anti-CD40 antibodies
Last updated:
Abstract:
This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
Status:
Grant
Type:
Utility
Filling date:
20 Jan 2017
Issue date:
21 Dec 2021